Zoetis Inc. (NYSE:ZTS) Shares Sold by Alpine Woods Capital Investors LLC

Alpine Woods Capital Investors LLC reduced its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 23.8% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 18,895 shares of the company's stock after selling 5,907 shares during the period. Alpine Woods Capital Investors LLC's holdings in Zoetis were worth $3,111,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the company. HUB Investment Partners LLC raised its stake in Zoetis by 4.7% during the 4th quarter. HUB Investment Partners LLC now owns 1,373 shares of the company's stock valued at $224,000 after acquiring an additional 62 shares during the last quarter. Coppell Advisory Solutions LLC lifted its position in Zoetis by 18.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 420 shares of the company's stock worth $68,000 after acquiring an additional 64 shares during the period. Ironwood Investment Management LLC lifted its position in Zoetis by 0.8% during the 4th quarter. Ironwood Investment Management LLC now owns 8,354 shares of the company's stock worth $1,361,000 after acquiring an additional 68 shares during the period. Legacy Financial Advisors Inc. lifted its position in Zoetis by 5.8% during the 4th quarter. Legacy Financial Advisors Inc. now owns 1,282 shares of the company's stock worth $209,000 after acquiring an additional 70 shares during the period. Finally, Quotient Wealth Partners LLC lifted its position in Zoetis by 2.3% during the 1st quarter. Quotient Wealth Partners LLC now owns 3,167 shares of the company's stock worth $521,000 after acquiring an additional 72 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on ZTS shares. Piper Sandler increased their price objective on Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. UBS Group decreased their price objective on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. Finally, Stifel Nicolaus cut Zoetis from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $212.13.

Zoetis Price Performance

NYSE ZTS traded down $3.89 during mid-day trading on Friday, hitting $154.91. The stock had a trading volume of 2,267,443 shares, compared to its average volume of 2,591,359. Zoetis Inc. has a 52-week low of $139.70 and a 52-week high of $200.33. The company has a market cap of $68.97 billion, a price-to-earnings ratio of 27.81, a P/E/G ratio of 2.63 and a beta of 0.91. The company has a 50 day simple moving average of $161.32 and a 200 day simple moving average of $161.86. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 1.12.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The firm had revenue of $2.22 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period last year, the business posted $1.38 EPS. Zoetis's quarterly revenue was up 1.4% on a year-over-year basis. Equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.29%. The ex-dividend date is Friday, July 18th. Zoetis's payout ratio is currently 35.91%.

Insiders Place Their Bets

In related news, EVP Roxanne Lagano sold 652 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the completion of the transaction, the executive vice president directly owned 15,129 shares of the company's stock, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.18% of the stock is owned by insiders.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.